Panel to discuss “Hemp in New England: Farming and CBD Opportunities Post-Farm Bill”Vancouver, BC - (NewMediaWire) - March 06, 2019 - Future Farm Technologies Inc. (the “Company” or “Future Farm”) (CSE: FFT) (OTCQB: FFRMF) is proud to announce that George Groccia, Future Farm’s organizational and operational manager, and Zachary Lapan, general manager for Future Farm Maine’s hemp production facilities, have been selected to speak at the New England Cannabis Convention (NECANN) in Boston on Saturday, March 23, 2019. NECANN is the east coast’s largest cannabis industry event, attracting the largest number of hemp and cannabis industry professionals in the Northeast.George and Zak will be speakers at the “Hemp in New England: Farming and CBD Opportunities Post-Farm Bill” panel, and George will serve as moderator. They will be joined by fellow panelists Julia Agron, outreach coordinator for the Northeast Sustainable Hemp Association (NOSHA); Bill Downing, former president of MassCANN/NORML; and Linda Noel of the Terrapin Hemp Cooperative. The session starts at 1:00 PM and will include time for the panel to address audience questions.With Future Farm’s successful fall 2018 harvest in Maine and the recent launch of the Company’s hemp seed sales website at FutureFarmShop.com, George and Zak bring hands-on experience to help the NECANN audience understand implications for farmers and CBD producers after the passage of the 2018 Farm Bill and how farmers and investors are seizing new opportunities in this emerging industry.To view the conference schedule and learn more about NECANN, visit https://www.necann.com/2019-boston/For further information about Future Farm Technologies, contact Investor Relations at investor@futurefarmtech.com or (888) 387-3761 ext. 710.On behalf of the Board,Future Farm Technologies Inc. William Gildea, CEO About Future Farm Technologies Inc. Future Farm is a Canadian company with holdings throughout North America including California, Massachusetts, Florida, Maine, Puerto Rico and Newfoundland. The Company’s mission is to advance sustainable agriculture through production of wholesale and retail cannabis products, including hemp. As a leader in its field, Future Farm is committed to using only the highest quality processes and products. Towards this goal, the Company acquires or partners with licensed cannabis operators, and acquires or develops leading technologies in cannabis production, breeding, genetics, and Controlled Environment Agriculture (CEA). Future Farm’s scalable, indoor CEA systems utilize minimal land, water and energy resources. The Company holds an exclusive, worldwide license to use a patented vertical farming technology that, when compared to traditional plant production methods, generates yields up to 10 times greater per square foot of land. Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. The Canadian Securities Exchange has not in any way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release. This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to ...

New York - (NewMediaWire) - March 06, 2019 - NexTech AR Solutions (the “Company” or “NexTech”) (OTC: NEXCF)(CSE: NTAR) (FSE: N29) is pleased to announce that it is working with Premier Health (CSE: PHGI, OTCQB: PHGRF, Frankfurt: 6PH) by exploring options to integrate NexTech’s AR into Premier Health’s App, which has the potential to reach Premier’s ecosystem of almost 3 million patients. NexTech is bringing a next generation web enabled augmented reality (AR) platform with Artificial Intelligence (AI) and analytics using a xAPI to the Cannabis industry, eCommerce, education, training, healthcare and video conferencing. This partnership marks an important step forward and the beginning of the company’s move into the multi-billion dollar health care industry and the many applications of AR in healthcare including: vein visualisation, surgical visualisation and education.NexTech will be working with Premier Health to develop education tools for health care professionals and patients alike – some of which will be created and commercialized content for third parties. Utilizing AR as a learning tool, in training healthcare professionals, creates a highly engaging, immersive educational experience which aids in retention and how well complex concepts can be grasped. For patients, AR can potentially empower them to play a more proactive role in their own care through aiding in self-diagnosis. And finally, for third party content, the companies will explore topics such as education on medications for Pharma and Continuous Positive Airway Pressure (CPAP) therapy systems for Sleep Apnea Clinics.In addition, the companies will investigate possible AR treatment delivery options. For example, in relation to physiotherapy, digital demonstrations can be mapped directly onto the movements patients perform as part of their recovery.“We are excited to work with the team at Premier Health to explore creating a custom AR and AI solution to address the healthcare market which represents another multi-billion dollar vertical ripe for disruption,” comments Evan Gappelberg, CEO of NexTech. “AR allows medical knowledge, skills and expertise to be shared remotely in the moment, ensuring they get where they are needed most.”“At Premier Health we pride ourselves in being at the forefront of changes in healthcare, so we are thrilled to be a part of the future of healthcare by enabling state of the art technological advancements to our patient centric telemedicine app,” said Dr. Essam Hamza, CEO of Premier Health. “AR has the potential to revolutionize both the access to data and the delivery of healthcare. The technology will help doctors and patients alike – doctors will have access to the latest and most relevant information about their patients while patients can use AR for self-education and improving the quality of treatment they receive.”About NexTech AR Solutions Corp.NexTech is bringing augmented reality (AR) to the Cannabis industry and to the masses by creating an AR ecosystem featuring eCommerce solutions for websites, AR learning and education tools, and AR live streaming for events. With just a few lines of embed code, the Company’s patent-pending technology can integrate into existing eCommerce platforms, providing retailers with a highly scalable platform that increases customer engagement and sales.To learn more, please follow us on Twitter, YouTube, Instagram, LinkedIn, and Facebook, or visit our website: https://www.nextechar.com.On behalf of the Board of NexTech AR Solutions Corp.“Evan Gappelberg”CEO and DirectorFor further information, please contact:Evan GappelbergChief Executive Officerinfo@nextechar.com Media contact:Erin HaddenFischTank Marketing and PRehadden@fischtankpr.comThe CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.Certain information contained herein may constitute “forward-looking information” under Canadian securities legislation. Generally, forward-looking information can be identified by the use of forward-looking terminology such as, “will be”, ...

Suwanee, GA - (NewMediaWire) - March 06, 2019 - SANUWAVE Health, Inc. (OTCQB: SNWV), an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, is excited to announce winning the JWC’s (Journal of Wound Care) 2019 Innovation in Chronic Wound Healing Award for dermaPACE® pressure shockwave for wound management.The JWC is the definitive wound-care journal and the leading source of up-to-date research and clinical information on everything related to tissue viability. The journal was first launched in 1992 and caters to the needs of the multidisciplinary team. JWC is the official journal of the World Union of Wound Healing Societies (WUWHS); it is also the media partner of the European Wound Management Association (EWMA) and affiliated to over 40 other associations, societies and charities. In the United States JWC is affiliated with AAWC, NPUAP and APWH giving unrivaled access to the global wound care community. The JWC Awards annually seek to recognize the significant work done by health care professionals in all fields of wound care, benchmarking standards within wound care to highlight the contributions and commitment that nurses, clinicians, scientists, researchers, and academics make to the development of wound-care research and practice. JWC winners are chosen by a prominent panel of expert judges that are representative of the diversity of disciplines and organizations that make up the sector. President of SANUWAVE, Shri Parikh, who was in attendance to receive the award in London on the evening of March 1, said, “SANUWAVE had significant competition in the category. It was a humbling honor to hear that SANUWAVE was chosen as the award winner to represent chronic wound healing innovation.”CEO and Chairman of the Board at SANUWAVE, Kevin Richardson, equally humbled, also weighed in stating that, “Any wound that does not follow a normal healing trajectory can be described as chronic. These patients often have a number of perplexing factors including a long and challenging treatment road ahead of them, that at times leads to amputation if the wound is not able to heal properly. Nothing gives us a greater feeling of reward and accomplishment than to see SANUWAVE contributing to the healing process, patient quality of life and science innovation. Pete Stegagno, Chief Operating Officer and Iulian Cioanta, Chief Science and Technology Officer made tremendous contributions to this innovation effort and we are thrilled to have these talented individuals on the SANUWAVE Executive Team.”If you would like to reference all 2019 JWC winners, please click here: https://www.jwcawards.com/winnersAbout the JWC (Journal of Wound Care Management)The JWC is England’s leading tissue viability and wound care professionals journal for nurses, medics, and researchers working in wound care. The JWC is essential reading for wound care professionals who are serious about providing the best possible support for the people in their care, and those who want to keep on top of the latest thinking and research. Registrants receive a free issue of Journal of Wound Care, unlimited access to the CPD launchpad, instant access to the 10 free supplement downloads, a free copy of the 'Wound Care Handbook' 2017/2018, cutting edge research articles from leading specialists, advice on managing tissue viability services, and coverage of the latest developments in tissue viability education.For additional information about the JWC, visit: https://info.journalofwoundcare.com/About SANUWAVE Health, Inc.SANUWAVE Health, Inc. (OTCQB:SNWV) (www.sanuwave.com) is a shock wave technology company initially focused on the development and commercialization of patented noninvasive, biological response activating devices for the repair and regeneration of skin, musculoskeletal tissue and vascular structures. SANUWAVE’s portfolio of regenerative medicine products and product candidates activate biologic signaling and angiogenic responses, producing new ...

Fort Lauderdale, FL, March 05, 2019 (NewMediaWire) -- Turnkey Capital Inc. (TKCI) today announced the Company has signed a Letter of Intent to acquire Collarmele Holdings, Inc., fka HealthSpan Medical Systems, Inc. Collarmele Holdings was recently acquired by HealthSpan Medical Systems, Inc. and the name of the company was changed to Collarmele Holdings, Inc. (CHI) (the Company). CHI is a real estate holding company that acquires, develops, redevelops and manages investments in mixed-use retail and healthcare properties throughout the United States.“In addition to our large scale Mixed Use redevelopment and Triple Net Lease pipeline, we believe there is real opportunity for the repurposing of underutilized retail and office space for medical, health and wellness services. The partnership of TBG and executives at Medixall will reimage the industry through a real estate lens creating a product that will be a highly attractive option for re-tenanting traditional shopping centers and mixed use space,” stated Joseph Tagliola, CEO of Collarmele Holdings, Inc. “Developers are not keeping pace with the growing number of large commercial spaces being vacated by retailers and e-commerce distractors as a result of economic market shifts.”“Because so many of our medical practitioner clients were experiencing challenges trying to manage their practices, we were looking for a partner who understood how to configure modern healthcare offices and facilities,” stated Neil Swartz, CEO of TKCI. “In Collarmele Partners, we found Healthcare development industry leaders who also brought retail, office and mixed-use expertise, and so much more. Commercial real estate owners are incorporating healthcare and wellness-related facilities to revitalize their properties. We are focusing on shared workspace models similar to those developed by innovators like WeWork,” Swartz added.The Collarmele Holdings partners’ confidence and momentum for this enterprise is solidly anchored by the track record of Collarmele Partners, LLC. Mr. Tagliola, and his development team, have been successfully reshaping development models for large scale commercial developments over the last several decades and have an understanding of what works in the marketplace. As former President of QIC US Properties (an $80B fund manager from Queensland Australia), former President of Retail and Office for Turnberry Associates, and Senior Executive Vice President of Westfield Corporation, Mr. Tagliola brings a depth of commercial development experience and execution to Collarmele Holdings.Collarmele Holdings focuses on three main areas of commercial real estate development:Health Triple Net development/leasing – traditional leasing options for larger businesses with long-term needs;Retail and Mixed-Use commercial development/leasing – the CHI team has decades of experience in creating commercial development for retail, office, hospitality (hotels/motels), and more.Collarmele Holdings is in talks with several commercial real estate property owners to determine which projects will be contracted shortly.TKCI anticipates the acquisition of Collarmele Holdings, Inc. will be completed in under 90 days. The Company will undergo a financial restructuring in conjunction with this transaction. Turnkey Capital Inc will retain its name and trading symbol.About Turnkey Capital Inc.Turnkey Capital Inc. (TKCI) is a business advisory company that aligns with, and builds value in, both private, public, and development-stage healthcare-related companies. TKCI acquired, built and developed the strategic direction of our companies which included: defining short and long-term strategic goals; identifying and planning for the critical success factors to reach these goals; identifying and addressing the challenges and operational improvements required to achieve the critical success factors and, ultimately, the strategic goals. In its next phase, as a healthcare and mixed-use retail real ...